An Ohio college student is expressing profound gratitude to the medical team that saved her life following complications from ...

As Carlton Moore's heart filled with joy at the sight of his newborn, his wife's stopped beating. How this Louisville family survived the gravest odds ...

Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

Discover how heart centers across the country are improving patient outcomes and reducing mortality rates through innovative approaches and advanced therapies.

Novartis has announced that it will be expanding its late-stage cardiovascular pipeline by acquiring Anthos Therapeutics for ...

For many decades, Albert Lean Don Hauge worked day in and day out as an EMT and paramedic, responding to people in need of emergency medical care. He also managed the ambulance service for Albert Lea ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Novartis (NVS) announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, ...

The pharmaceutical giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to ...

A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...